Polyarticular arthritis and spinal muscular atrophy in acid ceramidase deficiency

18Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

Survival of motor neuron 1-negative spinal muscular atrophy (SMA) is heterogeneous and remains a diagnostic challenge. The clinical spectrum continues to expand and ∼33 genes have been identified to date. The present report describes a 9-year-old girl with novel clinical phenotype of a patient with polyarticular arthritis followed by symptoms of SMA due to acid ceramidase deficiency. Whole exome sequencing identified compound heterozygous pathogenic mutation in the N-acylsphingosine amidohydrolase 1 gene. Functional assay with leukocyte acid ceramidase activity showed a decreased level in the proband confirming pathogenicity of the mutations. Mutations of N-acylsphingosine amidohydrolase 1 are known to separately cause Farber disease (arthritis, subcutaneous nodules, and dysphonia) or SMA with progressive myoclonic epilepsy. The present combined phenotype is novel, bringing together SMA with progressive myoclonic epilepsy and Farber disease and establishing a phenotypic spectrum. Acid ceramidase deficiency is an important consideration in patients presenting with polyarticular arthritis and motor neuron disease.

Cite

CITATION STYLE

APA

Teoh, H. L., Solyom, A., Schuchman, E. H., Mowat, D., Roscioli, T., Farrar, M., & Sampaio, H. (2016). Polyarticular arthritis and spinal muscular atrophy in acid ceramidase deficiency. Pediatrics, 138(4). https://doi.org/10.1542/peds.2016-1068

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free